Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STUB1 divergent transcript (STUB1-DT), also known as LINC02867, LA16c-313D11.9, and long intergenic non-protein coding RNA 2867, is a long non-coding RNA gene. It does not encode a protein and does not act as a receptor, enzyme, or drug target. Most information available for “STUB1” refers to the protein-coding gene STUB1, which encodes CHIP, an E3 ubiquitin ligase essential for protein quality control and involved in pathways such as stress response, neurodegeneration, and oncogenesis[1][3]. However, STUB1-DT itself is not considered a classical therapeutic target and lacks experimentally validated biological or disease associations. If the intended query was the protein-coding STUB1 gene, this is a distinct, well-characterized E3 ubiquitin ligase with established roles in proteostasis, cell signaling, neurodegeneration, and oncogenesis[1][2][3]. However, as asked, "STUB1 divergent transcript" or "LINC02867" itself is unlikely to be a target and is not functionally characterized at this time[3].
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2867 (LINC02867).